J.M.G.H. van Riel

The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies

Lindsay Angus, Marcel Smid, Saskia M. Wilting et al. · Nature Genetics · 2019 · 324 citations

Breast Oncology, Engineering, Somatic Variant +11

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

D.J.A. Lobbezoo, Roel J.W. van Kampen, Adri C. Voogd et al. · Breast Cancer Research and Treatment · 2013 · 239 citations

Breast Oncology, Medicine, Pathology +7

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?

D.J.A. Lobbezoo, Roel J.W. van Kampen, Adri C. Voogd et al. · British Journal of Cancer · 2015 · 233 citations · Full text

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

Vivianne C. G. Tjan‐Heijnen, Irene E.G. van Hellemond, Petronella G.M. Peer et al. · The Lancet Oncology · 2017 · 157 citations

Medicine, Clinical Trials, Gynecology +10

Gemcitabine–radiotherapy in patients with locally advanced pancreatic cancer

Sebastian Lange, C.J. van Groeningen, Otto W.M. Meijer et al. · European Journal of Cancer · 2002 · 82 citations

Radiation Medicine, Pancreatic Cancer, Medicine +3